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1. Introduction 
Bacterial lipopolysaccharides (LPS, endotoxins) 
cause many physiologic hanges in mammals [ 11, 
except in one outstanding mouse strain, C3H/HeJ, 
that has been shown to be resistant towards LPS. Its 
unrespon~veness is genetically determ~ed by a single 
autosomal dominant gene [Z 1, and includes the 
following normal aspects of endotoxicity: polyclonal 
B-cell activation [3], adjuvant action [4], mito- 
genicity [2], endotoxic shock [5], enhancement of
non-specific resistance to infections [6], polymorpho- 
nuclear leukocyte changes [7], protection against 
X-irraditation [8], inhibition of tolerance induction 
[9], and induction of glucocorticoid antagonizing 
factor [lo]. 
We have been i terested in the immediate LPS 
deto~f~g potential of weakened mammals in 
relation to the pathogenicity of LPS, and we showed 
that the plasma HDL (high density lipoprotein)- 
associated arylesterase [l l] binds to LPS in vitro 
[ 121 and is induced in vivo in SPF (specific pathogen- 
free) mice in concert with characteristic lipoprotein 
changes [ 131. These findings may strengthen the 
views of Skames on the immediate nzymatic degrada- 
tion of LPS by lipoprotein esterase 1141, but on the 
other hand there is little - if any - direct evidence of 
degradation of LPS, as reviewed in [IS]. 
We chose the C3H/HeJ non-responder strain for 
tests of the imme~ate reactions towards LPS, and 
7I.J. Back died on October 2, 1977 
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this paper shows that LPS induces characteristic 
changes in this strain in plasma lipoprotein (HDL) in 
addition to a considerable increase of HDGassociated 
arylesterase activity. We conclude that lipoprotein is 
part of the general response against LPS and that 
C3H/HeJ is not a non-responder asconcerns this 
response. 
2. Experimental procedures 
2.1. Endotoxins 
E. coli type 026 LPS (trichloroacetic acid-extracted) 
and E. coli type 055:BS LPS (phenol-extracted) were 
obtained from Difco Laboratories, Detroit, MI, USA. 
E. co& type 0124 LPS was prepared by phenol extrac- 
tion as described in [13]. LPS was adm~istered by 
~trape~tone~ and intra~nous injection of specified 
amounts of LPS in 0.2 fi saline. 
2.2. Mouse strains 
Strains were kept at conventional conditions at the 
State Serum Institute: C3H/HeJ/Ssc, C3H/FuAa/Ssc, 
and C57/B16/Ssc. The reported experiments are 
based upon experience with about 100 LPS non- 
responder C3H/HeJ mice. The non-responsiveness of 
the C3HfHeJ was determined according to the lacking 
of mitogenicity of phenol-extracted LPS (055 and 
0124). Figure 1 shows the in vitro proliferative 
response towards LPS (026,055, and 0124) as well 
as towards PHA (see 2.4) of spleen cells from C3H/ 
HeJ and C57/B16. 
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Fig.1. Mitogen-induced I)NAsynthetic response of C3H/HeJ 
(0) and C57/B16 (m) spleen cells. A cpm values given after 
substraction of cpm obtained in cultures without addition of 
any stimulator. The cpm values of non-stimulated C3H/HeJ 
or CJ7/B16 cultures were 2256 f 142 cpm or 1999 f 698 
cpm, respectively. The maximum response on day 3 of culture 
with LPS extracts, and the maximum response on day 2 with 
PHA is given. The stimulation shown here with LPS in C57f 
Bl and with PHA (both strains) is within the range normally 
observed in our experiments [181. 
2.3. Preparation of lymphocy te suspensions 
Single cell suspensions were made from spleens as 
described previously [16,171. 
2 A. In vitro functional assay 
The in vitro lymphopro~ferative response was 
performed as described previously [18]. Shortly, 
2 X 105 lymphoc~es were cultured in 0.2 ml of 
BP&II 1640 medium with or without LPS or PI-IA 
~hytohemag~ut~in) for from 1 to 6 days at 37°C 
and 5% COZ, the last 18 h in the presence of [3H]- 
thymidine, Incorporation of labelled thymidine was 
determined by liquid scintillation counting. 
2.5. Analyses 
Crossed immunoeiectrophoresis and visual estima- 
tion of HDL-associated arylesterase [ 111 was per- 
formed as described earlier [ 131. Rabbit immuno- 
globulins for ~m~~lectrophore~s of mouse serum 
proteins were prepared from 5 rabbits immunized 
with small doses of mouse serum according to [ 191 
and were concentrated 6 times relative to the antiserum. 
Results 
LPS was given to C3H/HeJ mice by intravenous 
and intraperitoneal injections and we analyzed the 
immediate reactions in plasma by crossed immuno- 
electrophoresis. We noted a characteristic shift in the 
lipoprotein pattern. Figure 2 shows details of the 
shifts of HDL and HDL-associated arylesterase of 
mice treated with LPS 026. Figure 2A is the normal 
pattern found in untreated mice. HDL is visualized 
not by lipid staining, but by specific staining for the 
HDL-associated arylesterase (A). Only the anodal 
part of the gel is shown and unspecific arboxylic 
esterase (‘Besterase [20], B) and a2-globulins 
(stained by unspecific dye-uptake, G) are taken as 
fix-points. Cholinesterase (‘C-esterase’ [20] ) is very 
weak and not seen here in this anodal part of the gel. 
Individual mice were killed and the blood was 
taken for analysis. Figure 2B-D shows the pattern 
4,8, and 32 h after intraperitoneal injection of LPS. 
After 4 h there appears an extra peak of HDL (flg.‘ZB, 
arrow). This peak also carries arylesterase activity. 
After. 8 h there is a complete shift of the HDL 
towards the cathode, and the shift becomes more and 
more pronounced until the HDL peak appears 
between the B-esterase and the oa-globulins (fig.2D). 
There is still an extra peak on the cathodic side of 
HDL after 32 h. After about 2 days the HDL reappears 
in the normal position on the anodic side of Besterase 
(not shown). 
When we judged the staining intensity of aryl- 
esterase visually ffig.1) we found an increase in the 
activity after LPS treatment with a m~mum about 
24 h after challenge. A qu~titative analysis for aryl- 
esterase in mouse plasma is desirable, ut not easily 
feasible because the overlapping activities of A and 
Besterases. 
To ascertain that these changes were not effects of 
contaminating mitogenic protein in LPS 026 we 
tested a similar commercial phenol-water xtracted 
LPS (E. coZi 055) and our own LPS phenol-extracted 
from E. coli type 0124. We found similar changes 
induced with these LPS in the electrophoretic proper- 
ties of HDL. Also the arylesterase activity increased 
con~derably as estimated visually to give a rn~rn~ 
one day after LPS treatment. 
Several doses were tested. Figure 2 is characteristic 
of the pattern observed with intraperitoneal injections 
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Fig.2. Crossed immunoelectrophoresis of serum from C3H/HeJ mice treated with endotoxin (enzyme-stained plates, only anodal 
part is shown). The time after LPS challenge (250 ~1 LPS type 026 given intraperitoneally) is indicated for each serum. The aryl- 
esterase activity outlines the HDL precipitate (marked with A, dashed lines and arrows). B and G (0) signify carboxylic esterase 
(Besterase) and o,-globulins respectively. The amount of serum analyzed was 0.5 ~1 and 1 ~1 antibody preparation was used per 
cm’. The fast and the second dimension electrophoresis are indicated by l+ and 2+. The bar indicates 1 cm. 
of LPS in doses that give a lethal response in other 
strains of mice (e.g., l-3 times the LDse in C3H/Fu 
responder mice and C57/B16). However, for each 
LPS there was a characteristic me-dependent electro- 
phoretic shift of HDL. When the LPS was given by 
intravenous injection, the time course of the lipo- 
protein response was much faster but the same 
general features of the electrophoretic shifts and the 
increase of arylesterase activity were maintained. 
Crossed immunoelectrophoretic analysis allows 
L--L--L__ 8 18 24 g 16 24 1 2.5 5 Hr 
Fig.3. Time course of the relative HDL changes in C3H/HeJ mice after challenge with LPS type 026 (A, 250 fig given intra- 
peritoneally), LPS type 0124 (B, 250 c(g given intraperitoneally), and LPS type 0124 (C, 100 pg given intravenously). The area of 
the HDL precipitate (roughly proportional to the HDL concentration) was measured by planimetry. Each point represents one or 
two animals and the range of measurements i indicated. The HDL in untreated animals figures as 100%. 
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q~titation of proteins and we quantitated lipo- 
protein by me~urement of the area enclosed by the 
HDL precipitate. Figure 3 shows the relative amounts 
of HDL observed in animals treated at different imes 
before bleeding. Figure 3A shows that LPS 026 given 
intraperitoneally induces a small but remaining drop 
in HDL. LPS 0124 given in the same way induces 
only a temporary drop in HDL followed by an increase 
to more than the normal amount after about 16 h 
(fig.3B). With intravenous challenge the drop in HDL 
is considerably more pronounced and occurs within 
the first 30 min after challenge. The HDL level 
slowly rises to the normal evel after one day (not 
shawn). 
4. Discussion 
When we used crossed immunoelectrophoresis to 
study the immediate response towards LPS we found 
that C3H/HeJ, the non-responder mouse strain, 
exhibited changes in lipoprotein and arylesterase 
activity as seen before in normal responder mice [13]. 
These changes were observed with Boivinextracted 
(026) as well as with Westph~~xtra~ted (055 and 
Of 24) LPS which excludes the mitogenic protein 
[4,21] as cause of our results, and thus we could 
demonstrate hat C3HjHeJ is capable of a non- 
immune response towards LPS. 
Therefore, the induction of arylesterase and the 
change of HDL may be parts of a general response 
which is independent of the immune response and 
independent of the expression of the Lps gene [22]. 
Recently Haas et al. showed that the C3H/HeJ is 
also capable of an ~rnunolo~c~ response towards 
LPS. The suppression of plaque-formin cells (PFC) 
formation was readily induced with LPS and found to 
be transferrable with spleen cells of LPS-treated 
C3HjHeJ mice f23]. Consequently we find that there 
are now good reasons to discontinue the use of the 
general terms ‘non-responder’ and ‘unresponsive’ 
without specific clarification. 
Earlier we noted a remarkable difference between 
SPF (specific pathogen-free) and non-SPF animals 
with respect o the lipoprotein-arylesterase response. 
When normal strains (BALBjc and C57Bl) were kept 
at SPF conditions the responses were similar to those 
described here, but when transferred to conventional 
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conditions these strains howed a high level of aryl- 
e&erase and the ele~trophore~~ shifts of lipoprotein 
were less pronounced [13]. Another aspect, which 
may also be noted in fig.2 here, is the relative decrease 
of the other esterase, the carboxylic esterase (fig.2B-D). 
There is a possibility that the decrease is anexpression 
of consumption of enzyme but there is no direct 
evidence for any enzymatic degradation of LPS [ 151. 
On the other hand, our results bring actuality to the 
early experiments of Skarnes who found that lipa- 
protein and enzyme coprecipitated with endotoxin 
when serum from LPS-treated animals was precipi- 
tated by specific antiserum against endotoxin [24]. In 
relation to this we note that the literature is highly 
suggestive of reactions between endotox~s and 
plasma proteins, including detoxifying proteins and 
lipoproteins [14,24-261, and in spite of the known 
blood cell receptors for LPS [27,28] the circulating 
LPS is found primarily in the cell-free plasma fraction 
([29] and Marina Freudenberg, personal communica- 
tion). 
The electrophoretic shift and change in morphology 
seen here for HDL and HDL-associated arylesterase 
after LPS treatment in vivo is analogous to the 
electrophoretic shift and change in morpholo~ of 
lipoproteins or other arnp~p~i~ proteins: After 
partial or total delipidation of lipoproteins 130,311, 
after staining of lipoproteins with lipophihc stains 
[32,33], and after reaction of membrane proteins 
with non-ionic or charged etergents [34,35] where 
in all cases the lipid constituents of the proteins are 
changed. The latter reaction has even been developed 
into a very sensitive analytical assay for intrinsic 
membrane proteins named ‘charge shift electro- 
phoresis’ 136,371. We interprete the changes of 
plasma lipoprotein after LPS treatment as charge 
shift changes in the lipid component of HDL due to 
LPS. Based upan the ~p~p~~~~ nature of HDL we 
find that HDL may serve as a general ~amphiphi~~ 
sink’ for components of lipid nature like LPS. 
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